Discrepant Bowel Perforation from a Primary Lesion after Chemotherapy of Diffuse Large B Cell Lymphoma.
10.4174/jkss.2009.76.1.61
- Author:
Ho Goon KIM
1
;
Mi Ran JUNG
;
Hyo KANG
;
Oh CHEONG
;
Jae Kyun JU
;
Young Kyu PARK
;
Seong Yeob RYU
;
Dong Yi KIM
;
Young Jin KIM
;
Shin Kon KIM
Author Information
1. Division of Gastoenterologic Surgery, Department of Surgery, Chonnam National University Medical School, Gwangju, Korea. dockim@chonnam.ac.kr
- Publication Type:Case Report
- Keywords:
Diffuse large B cell lymphoma;
Chemotherapy;
Perforation;
Early detection
- MeSH:
Gastrointestinal Tract;
Humans;
Lymphoma;
Lymphoma, B-Cell;
Lymphoma, Non-Hodgkin;
Prognosis
- From:Journal of the Korean Surgical Society
2009;76(1):61-65
- CountryRepublic of Korea
- Language:English
-
Abstract:
Diffuse large B cell lymphoma is the most common type of non-Hodgkin's lymphoma, representing approximately one-third of all cases and involving the gastrointestinal tract in about 18%. With the development of modern chemotherapeutic regimens and advances in medical care, the prognosis for malignant lymphoma can be excellent. However, because of the aggressive adjuvant therapy required, complications such as bowel perforation may be fatal. In cases of chemotherapy for malignant lymphoma, we should keep in mind the possibility of perforation of the bowel after chemotherapy. Early detection is important to save patients.
